Live Breaking News & Updates on European society of cardiology congress

Stay informed with the latest breaking news from European society of cardiology congress on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in European society of cardiology congress and stay connected to the pulse of your community

It helps protect your heart, but could too much 'good' cholesterol be bad for your brain?

Currently the focus is very much on lowering levels of artery-clogging LDL - or 'bad' cholesterol. But should we all be looking closely at our levels of HDL 'good' cholesterol, too?

Brompton , Medway , United-kingdom , Australia , London , City-of , Harefield , Hillingdon , Australian , British , David-middleton , Tina-khan

FDA Clears First AI-ECG Screening Tools for CV Care: What's Next Is Up for Grabs

These first “SAMDs” leverage ECGs to pick up worsening EF and hypertrophic cardiomyopathy, but more loom on the horizon.

Tufts-medical-center , Massachusetts , United-states , Boston , American , Los-angeles , Paul-friedman , David-ouyang , Mitchell-psotka , Jayme-strauss , American-heart-association , Falls-church

FDA Clears AI-ECG Screening Tools for CV Care: What's Next Is Up for Grabs

These “SAMDs” leverage ECGs to pick up worsening EF and hypertrophic cardiomyopathy, but more loom on the horizon.

Tufts-medical-center , Massachusetts , United-states , Boston , American , Jayme-strauss , Los-angeles , David-ouyang , Mitchell-psotka , Paul-friedman , Vascular-institute , Falls-church

First Pulsed-Field Ablation System Gets FDA Approval

The PulseSelect PFA system, approved in Europe last month, is indicated for the treatment of both paroxysmal and persistent AF.

Boston , Massachusetts , United-states , Drug-administration , European-society-of-cardiology-congress , Medtronic , Boston-scientific , European-society , Cardiology-congress ,

BridgeBio Pharma: Taking Some Profits (NASDAQ:BBIO)

BridgeBio Pharma: Taking Some Profits (NASDAQ:BBIO)
seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.

Winstons-churchill , Bio-pharma , Doing-research , Company-website , Diverse-team-of-multi , Cantor-fitzgerald , Medicine-laboratory , Cm-grand-view-research , Company-presentation , Nasdaq , European-society-of-cardiology-congress

Heart health: secrets for a healthy heart

Heart health: secrets for a healthy heart
theaustralian.com.au - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theaustralian.com.au Daily Mail and Mail on Sunday newspapers.

Milan , Lombardia , Italy , Nottingham , United-kingdom , Australia , University-college , New-south-wales , United-states , Britain , Australian , American

Heart health: secrets for a healthy heart

Heart health: secrets for a healthy heart
theaustralian.com.au - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theaustralian.com.au Daily Mail and Mail on Sunday newspapers.

University-college , New-south-wales , Australia , United-states , United-kingdom , Milan , Lombardia , Italy , Nottingham , Scotland , American , Australian

BridgeBio Pharma Presents Additional Clinical Outcomes Data from the Phase 3 ATTRibute-CM Study of Acoramidis in Patients with Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM)

The company intends to file a New Drug Application (NDA) for acoramidis with the U.S. Food and Drug Administration (FDA) by end of 2023

United-states , American , Jonathan-fox , Bio-cardiorenal , Us-social-security-administration , European-society-of-cardiology-congress , Steering-committee , Us-department-of-health , University-of-south-carolina , Bridgebio-pharma-inc , American-heart-association

BridgeBio Pharma Presents Additional Clinical Outcomes Data from the Phase 3 ATTRibute-CM Study of Acoramidis in Patients with Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM)

- As previously announced, the primary endpoint was met with a highly statistically significant p-value - The placebo and acoramidis time-to-first event Kaplan-Meier curves for a composite of...

United-states , Ukraine , American , Vikram-bali , Exchange-commission , Bio-pharma-inc , Twitter , European-society-of-cardiology-congress , Nasdaq , Securities-exchange , American-heart-association , Bridgebio-pharma-inc

Weight loss drug Wegovy reduces heart disease risk

Among adults with established cardiovascular disease who were overweight or had obesity but did not have diabetes, Wegovy cut the risk of major adverse cardiovascular.

United-states , Philadelphia , Pennsylvania , Denmark , American , Danish , Eric-topol , Eli-lilly , Martin-lange , European-society-of-cardiology-congress , Drug-administration , American-heart-association